Product Details for ANDA 062333
MEZLIN (MEZLOCILLIN SODIUM MONOHYDRATE)
EQ 1GM BASE/VIAL
Marketing Status: Discontinued
EQ 2GM BASE/VIAL
Marketing Status: Discontinued
EQ 3GM BASE/VIAL
Marketing Status: Discontinued
EQ 4GM BASE/VIAL
Marketing Status: Discontinued
EQ 1GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: MEZLOCILLIN SODIUM MONOHYDRATE
Proprietary Name: MEZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062333
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
MEZLIN (MEZLOCILLIN SODIUM MONOHYDRATE)
Proprietary Name: MEZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062333
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 2GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: MEZLOCILLIN SODIUM MONOHYDRATE
Proprietary Name: MEZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062333
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
MEZLIN (MEZLOCILLIN SODIUM MONOHYDRATE)
Proprietary Name: MEZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062333
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 3GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: MEZLOCILLIN SODIUM MONOHYDRATE
Proprietary Name: MEZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 3GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062333
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
MEZLIN (MEZLOCILLIN SODIUM MONOHYDRATE)
Proprietary Name: MEZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 3GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062333
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 4GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: MEZLOCILLIN SODIUM MONOHYDRATE
Proprietary Name: MEZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 4GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062333
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: MEZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 4GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062333
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status: Discontinued
Patent and Exclusivity Information